Nolan Thomas

Conflicts of Interest MWH and SYL receive funding from NIH NICHD (R01 1R01HD116793-01). MWH holds Invention Disclosure #109831, P240274; and MWH is a board member of Neonatal Kidney Collaborative Board Member. Data Availability Statement The data are all from the published articles cited in the references. Supporting Information Filename Description jcph70135-sup-0001-SuppMat.docx184.4 KB Supporting Information References 1, , , et al.

Introduction Seizures affect 1 to 4 per 1000 neonates with an incidence as high as 22% in preterm neonates.1, 2 Among neonates with seizures, up to one third of term and half of preterm neonates die, and half of survivors have lifelong disabilities.3 Phenobarbital is the first-line pharmacotherapy for neonatal seizures; however, one third of neonates treated with phenobarbital experience adverse events such as hypotension and respiratory suppression.4 Additionally, phenobarbital may harm the...

Thursday, 02 March 2017 Author: Christina Goodrich, Nolan Thomas When one thinks of cyber-espionage, images abound of young people with iridescent faces from the glow of computer screens, listening to metal music, and living in their parents’ basement hacking into banks and public systems for thrill, notoriety, and (sometimes) money. Such images are, of course, clichés.